يعرض 861 - 880 نتائج من 1,784 نتيجة بحث عن '(( 9 11 decrease ) OR ( 10 (((meer OR per) decrease) OR (((nn decrease) OR (a decrease)))) ))*', وقت الاستعلام: 0.23s تنقيح النتائج
  1. 861
  2. 862

    Salvia fruticosa Induces Vasorelaxation in Rat Isolated Thoracic Aorta: Role of the PI3K/Akt/eNOS/NO/cGMP Signaling Pathway حسب Anwar, M. Akhtar

    منشور في 2017
    "…Pretreatment of endothelium-intact rings with L-NAME (a non-selective inhibitor of nitric oxide synthase, 100 µM), or ODQ (an inhibitor of soluble guanylyl cyclase, 10 µM) significantly diminished SF-mediated vasorelaxation. …"
    احصل على النص الكامل
    احصل على النص الكامل
  3. 863
  4. 864
  5. 865
  6. 866
  7. 867
  8. 868
  9. 869

    Repositioning for pressure injury prevention in adults. حسب Gillespie, Brigid M

    منشور في 2020
    "…The intervention was reported to be cost-saving compared with standard care (nursing time cost per patient EUR 206.60 versus EUR 253.10, incremental difference EUR -46.50, 95% CI EUR -1.25 to EUR -74.60). …"
    احصل على النص الكامل
    احصل على النص الكامل
  10. 870
  11. 871
  12. 872

    Evaluation of different personalized ventilation air terminal devices: Inhalation vs. clothing-mediated exposures حسب Al Assaad, Douaa

    منشور في 2021
    "…The model was validated experimentally in a climatic chamber by comparing real-time particle mass concentration near a thermal manikin. …"
    احصل على النص الكامل
    احصل على النص الكامل
  13. 873
  14. 874
  15. 875
  16. 876
  17. 877

    Electrically conductive hybrid organic crystals as flexible optical waveguides حسب Li, Liang

    منشور في 2022
    "…In cyclic operation mode, their conductivity decreases less than 1% after 10,000 thermal cycles. …"
    احصل على النص الكامل
  18. 878
  19. 879
  20. 880

    Trends in prescribing and outcomes in obese versus non-obese patients receiving rivaroxaban therapy: an observational study using real-world data حسب Alalawneh, Majdoleen

    منشور في 2023
    "…Results The number of patients initiated on rivaroxaban therapy significantly increased from 152 (3.3%) in 2015 to 1342 (28.9%) in 2020 (p <0.001). Within BMI categories, a similar increasing trend was observed in underweight, normal, and overweight patients, while from 2018 to 2020, there was a decreasing trend in rivaroxaban prescribing in all obese classes. …"
    احصل على النص الكامل
    احصل على النص الكامل